{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:02:44Z","timestamp":1791216164853,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":645,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1038\/mtna.2015.24","type":"journal-article","created":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T15:22:18Z","timestamp":1441120938000},"page":"e250","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Intravitreal Injection of Splice-switching Oligonucleotides to Manipulate Splicing in Retinal Cells"],"prefix":"10.1016","volume":"4","author":[{"given":"Xavier","family":"G\u00e9rard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Perrault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Munnich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josseline","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Rozet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mtna.2015.24_bib1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/13816810802232768","article-title":"Leber congenital amaurosis: from darkness to spotlight","volume":"29","author":"Kaplan","year":"2008","journal-title":"Ophthalmic Genet"},{"key":"10.1038\/mtna.2015.24_bib2","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","article-title":"Effect of gene therapy on visual function in Leber's congenital amaurosis","volume":"358","author":"Bainbridge","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1038\/mtna.2015.24_bib3","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1089\/hum.2008.107","article-title":"Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial","volume":"19","author":"Hauswirth","year":"2008","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mtna.2015.24_bib4","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","article-title":"Safety and efficacy of gene transfer for Leber's congenital amaurosis","volume":"358","author":"Maguire","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1038\/mtna.2015.24_bib5","first-page":"2","article-title":"The dynamic cilium in human diseases","volume":"3","author":"D'Angelo","year":"2009","journal-title":"PathoGenetics"},{"key":"10.1038\/mtna.2015.24_bib6","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1083\/jcb.201006105","article-title":"CEP290 tethers flagellar transition zone microtubules to the membrane and regulates flagellar protein content","volume":"190","author":"Craige","year":"2010","journal-title":"J Cell Biol"},{"key":"10.1038\/mtna.2015.24_bib7","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1172\/JCI69448","article-title":"Disruption of CEP290 microtubule\/membrane-binding domains causes retinal degeneration","volume":"123","author":"Drivas","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1038\/mtna.2015.24_bib8","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/humu.21337","article-title":"CEP290, a gene with many faces: mutation overview and presentation of CEP290base","volume":"31","author":"Coppieters","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1038\/mtna.2015.24_bib9","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1086\/507318","article-title":"Mutations in the CEP290 (NPHP6) gene are a frequent cause of Leber congenital amaurosis","volume":"79","author":"den Hollander","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1038\/mtna.2015.24_bib10","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/humu.9485","article-title":"Spectrum of NPHP6\/CEP290 mutations in Leber congenital amaurosis and delineation of the associated phenotype","volume":"28","author":"Perrault","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1038\/mtna.2015.24_bib11","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ajo.2007.08.022","article-title":"Leber congenital amaurosis - a model for efficient genetic testing of heterogeneous disorders: LXIV Edward Jackson Memorial Lecture","volume":"144","author":"Stone","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1038\/mtna.2015.24_bib12","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1038\/mtna.2012.21","article-title":"AON-mediated Exon Skipping Restores Ciliation in Fibroblasts Harboring the Common Leber Congenital Amaurosis CEP290 Mutation","volume":"1","author":"Gerard","year":"2012","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1038\/mtna.2015.24_bib13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-126-4-199702150-00001","article-title":"Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial","volume":"126","author":"Lalezari","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1038\/mtna.2015.24_bib14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1517\/17425247.4.4.371","article-title":"Novel approaches to retinal drug delivery","volume":"4","author":"Janoria","year":"2007","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1038\/mtna.2015.24_bib15","doi-asserted-by":"crossref","first-page":"e79369","DOI":"10.1371\/journal.pone.0079369","article-title":"Unexpected CEP290 mRNA splicing in a humanized knock-in mouse model for Leber congenital amaurosis","volume":"8","author":"Garanto","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/mtna.2015.24_bib16","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1089\/hum.2013.234","article-title":"Development of therapeutic splice-switching oligonucleotides","volume":"25","author":"Disterer","year":"2014","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mtna.2015.24_bib17","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/jmg.2010.077883","article-title":"Abnormal respiratory cilia in non-syndromic Leber congenital amaurosis with CEP290 mutations","volume":"47","author":"Papon","year":"2010","journal-title":"J Med Genet"},{"key":"10.1038\/mtna.2015.24_bib18","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/hmg\/ddr025","article-title":"The N-terminal region of centrosomal protein 290 (CEP290) restores vision in a zebrafish model of human blindness","volume":"20","author":"Baye","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mtna.2015.24_bib19","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/ng0397-236","article-title":"A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy","volume":"15","author":"Allikmets","year":"1997","journal-title":"Nat Genet"},{"key":"10.1038\/mtna.2015.24_bib20","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.neuroscience.2008.06.042","article-title":"Functional and structural modifications during retinal degeneration in the rd10 mouse","volume":"155","author":"Barhoum","year":"2008","journal-title":"Neuroscience"},{"key":"10.1038\/mtna.2015.24_bib21","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1167\/iovs.13-11673","article-title":"Subretinal gene therapy of mice with Bardet-Biedl syndrome type 1","volume":"54","author":"Seo","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/mtna.2015.24_bib22","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ejhg.2012.137","article-title":"Novel VCAN mutations and evidence for unbalanced alternative splicing in the pathogenesis of Wagner syndrome","volume":"21","author":"Kloeckener-Gruissem","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"10.1038\/mtna.2015.24_bib23","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.tig.2011.02.004","article-title":"Genetic therapies for RNA mis-splicing diseases","volume":"27","author":"Hammond","year":"2011","journal-title":"Trends Genet"},{"key":"10.1038\/mtna.2015.24_bib24","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrg2164","article-title":"Splicing in disease: disruption of the splicing code and the decoding machinery","volume":"8","author":"Wang","year":"2007","journal-title":"Nat Rev Genet"},{"key":"10.1038\/mtna.2015.24_bib25","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1073\/pnas.0633863100","article-title":"Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts","volume":"100","author":"Skordis","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mtna.2015.24_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-3-540-34449-0_4","article-title":"SR proteins as potential targets for therapy","volume":"44","author":"Soret","year":"2006","journal-title":"Prog Mol Subcell Biol"},{"issue":"Pt 3","key":"10.1038\/mtna.2015.24_bib27","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1042\/BST0360483","article-title":"Substances that can change alternative splice-site selection","volume":"36","author":"Sumanasekera","year":"2008","journal-title":"Biochem Soc Trans"},{"key":"10.1038\/mtna.2015.24_bib28","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/mt.2008.205","article-title":"Guidelines for antisense oligonucleotide design and insight into splice-modulating mechanisms","volume":"17","author":"Aartsma-Rus","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mtna.2015.24_bib29","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1038\/mtna.2012.3","article-title":"Antisense Oligonucleotide (AON)-based Therapy for Leber Congenital Amaurosis Caused by a Frequent Mutation in CEP290","volume":"1","author":"Collin","year":"2012","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1038\/mtna.2015.24_bib30","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4161\/rna.7.4.12264","article-title":"Antisense-mediated modulation of splicing: therapeutic implications for Duchenne muscular dystrophy","volume":"7","author":"Aartsma-Rus","year":"2010","journal-title":"RNA Biol"},{"key":"10.1038\/mtna.2015.24_bib31","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1011367","article-title":"Systemic administration of PRO051 in Duchenne's muscular dystrophy","volume":"364","author":"Goemans","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1038\/mtna.2015.24_bib32","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(11)60756-3","article-title":"Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study","volume":"378","author":"Cirak","year":"2011","journal-title":"Lancet"},{"key":"10.1038\/mtna.2015.24_bib33","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/bjo.83.7.852","article-title":"Dynamics of phosphorothioate oligonucleotides in normal and laser photocoagulated retina","volume":"83","author":"Shen","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1038\/mtna.2015.24_bib34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/labinvest.3780409","article-title":"Preclinical evaluation of a phosphorothioate oligonucleotide in the retina of rhesus monkey","volume":"82","author":"Shen","year":"2002","journal-title":"Lab Invest"},{"key":"10.1038\/mtna.2015.24_bib35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev.med.55.091902.104408","article-title":"Progress in antisense technology","volume":"55","author":"Crooke","year":"2004","journal-title":"Annu Rev Med"},{"key":"10.1038\/mtna.2015.24_bib36","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/humu.20565","article-title":"Centrosomal-ciliary gene CEP290\/NPHP6 mutations result in blindness with unexpected sparing of photoreceptors and visual brain: implications for therapy of Leber congenital amaurosis","volume":"28","author":"Cideciyan","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1038\/mtna.2015.24_bib37","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1167\/iovs.09-3734","article-title":"Differential macular morphology in patients with RPE65-, CEP290-, GUCY2D-, and AIPL1-related Leber congenital amaurosis","volume":"51","author":"Pasadhika","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/mtna.2015.24_bib38","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/hmg\/ddr022","article-title":"Cone photoreceptors are the main targets for gene therapy of NPHP5 (IQCB1) or NPHP6 (CEP290) blindness: generation of an all-cone Nphp6 hypomorph mouse that mimics the human retinal ciliopathy","volume":"20","author":"Cideciyan","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mtna.2015.24_bib39","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jaapos.2013.09.015","article-title":"Intravitreal foscarnet for recurring CMV retinitis in a congenitally infected premature infant","volume":"18","author":"Tawse","year":"2014","journal-title":"J AAPOS"},{"key":"10.1038\/mtna.2015.24_bib40","doi-asserted-by":"crossref","first-page":"vii","DOI":"10.1089\/oli.1.1998.8.vii","article-title":"Vitravene\u2013another piece in the mosaic","volume":"8","author":"Crooke","year":"1998","journal-title":"Antisense Nucleic Acid Drug Dev"},{"key":"10.1038\/mtna.2015.24_bib41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.mayocp.2011.10.001","article-title":"The expanding role of vascular endothelial growth factor inhibitors in ophthalmology","volume":"87","author":"Stewart","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1038\/mtna.2015.24_bib42","doi-asserted-by":"crossref","first-page":"291ra97","DOI":"10.1126\/scitranslmed.aaa5370","article-title":"Basal exon skipping and genetic pleiotropy: A predictive model of disease pathogenesis","volume":"7","author":"Drivas","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1038\/mtna.2015.24_bib43","doi-asserted-by":"crossref","first-page":"291fs24","DOI":"10.1126\/scitranslmed.aac6504","article-title":"Understanding disease pleiotropy: From puzzle to solution","volume":"7","author":"Rozet","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1038\/mtna.2015.24_bib44","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1126\/science.8430317","article-title":"The skipping of constitutive exons in vivo induced by nonsense mutations","volume":"259","author":"Dietz","year":"1993","journal-title":"Science"},{"key":"10.1038\/mtna.2015.24_bib45","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrg775","article-title":"Listening to silence and understanding nonsense: exonic mutations that affect splicing","volume":"3","author":"Cartegni","year":"2002","journal-title":"Nat Rev Genet"},{"key":"10.1038\/mtna.2015.24_bib46","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S1097-2765(02)00635-4","article-title":"Nonsense-associated altered splicing: a frame-dependent response distinct from nonsense-mediated decay","volume":"10","author":"Wang","year":"2002","journal-title":"Mol Cell"},{"key":"10.1038\/mtna.2015.24_bib47","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1167\/iovs.09-5074","article-title":"A novel nonsense mutation in CEP290 induces exon skipping and leads to a relatively mild retinal phenotype","volume":"51","author":"Littink","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/mtna.2015.24_bib48","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1093\/nar\/gkg616","article-title":"ESEfinder: A web resource to identify exonic splicing enhancers","volume":"31","author":"Cartegni","year":"2003","journal-title":"Nucleic Acids Res"}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225311630035X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225311630035X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T20:30:27Z","timestamp":1537389027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S216225311630035X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":48,"alternative-id":["S216225311630035X"],"URL":"https:\/\/doi.org\/10.1038\/mtna.2015.24","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]},"article-number":"e250"}}